Current Ratio of Transcode Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Transcode Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Transcode Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 338%, a 111% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 338% +178% +111% 30 Sep 2025
Q2 2025 350% +187% +115% 30 Jun 2025
Q1 2025 254% +88% +53% 31 Mar 2025
Q4 2024 194% +66% +52% 31 Dec 2024
Q3 2024 160% +23% +16% 30 Sep 2024
Q2 2024 163% -2% -1.2% 30 Jun 2024
Q1 2024 166% -77% -32% 31 Mar 2024
Q4 2023 128% -313% -71% 31 Dec 2023
Q3 2023 137% -539% -80% 30 Sep 2023
Q2 2023 165% -803% -83% 30 Jun 2023
Q1 2023 243% -583% -71% 31 Mar 2023
Q4 2022 440% 31 Dec 2022
Q3 2022 677% 30 Sep 2022
Q2 2022 968% 30 Jun 2022
Q1 2022 826% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.